MARKET

GCTK

GCTK

Glucotrack
NASDAQ
0.4899
-0.0270
-5.22%
After Hours: 0.4701 -0.0198 -4.04% 19:59 02/14 EST
OPEN
0.4890
PREV CLOSE
0.5169
HIGH
0.6797
LOW
0.4557
VOLUME
6.04M
TURNOVER
--
52 WEEK HIGH
99.00
52 WEEK LOW
0.4557
MARKET CAP
5.10M
P/E (TTM)
-0.0086
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GCTK last week (0203-0207)?
Weekly Report · 4d ago
GLUCOTRACK INC: FILES FOR OFFERING OF 2.64 MLN OF COMMON STOCK - SEC FILING
Reuters · 02/05 14:30
GlucoTrack’s $3.03M Stock Offering Agreement Announced
TipRanks · 02/05 14:28
Glucotrack announces pricing of $3M public offering
Seeking Alpha · 02/04 20:22
GlucoTrack prices offering of 2.6M shares of common stock at $1.15
TipRanks · 02/04 17:30
Glucotrack Announces Pricing Of $3M Public Offering Of ~2.6M Shares Of Common Stock At a Price Of $1.15/Share
Benzinga · 02/04 17:25
GLUCOTRACK INC - OFFERING PRICE SET AT $1.15 PER SHARE
Reuters · 02/04 17:24
GLUCOTRACK, INC. ANNOUNCES PRICING OF $3.0 MILLION PUBLIC OFFERING
Reuters · 02/04 17:24
More
About GCTK
Glucotrack, Inc. is focused on the design, development, and commercialization of technologies for people with diabetes. The Company is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. It has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The Company has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.

Webull offers GlucoTrack Inc stock information, including NASDAQ: GCTK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GCTK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GCTK stock methods without spending real money on the virtual paper trading platform.